3.02 - 3.02
2.85 - 3.74
400 / 3.8K (Avg.)
12.58 | 0.24
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-10.63%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-3.06%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-45.06%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-58.66%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-49.00%
Negative net income growth while M7U.DE stands at 4.03%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-52.50%
Negative EPS growth while M7U.DE is at 2.38%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-52.50%
Negative diluted EPS growth while M7U.DE is at 2.38%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
3.75%
Share count expansion well above M7U.DE's 1.07%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
3.75%
Diluted share count expanding well above M7U.DE's 1.46%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
67.13%
OCF growth under 50% of M7U.DE's 297.42%. Michael Burry might suspect questionable revenue recognition or rising costs.
178.77%
FCF growth 50-75% of M7U.DE's 247.30%. Martin Whitman would see if structural disadvantages exist in generating free cash.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
37.99%
3Y revenue/share CAGR above 1.5x M7U.DE's 18.88%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
177.01%
3Y net income/share CAGR similar to M7U.DE's 170.19%. Walter Schloss would attribute it to shared growth factors or demand patterns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
132.12%
3Y equity/share CAGR at 50-75% of M7U.DE's 197.81%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
15.97%
3Y dividend/share CAGR of 15.97% while M7U.DE is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-11.07%
Firm’s AR is declining while M7U.DE shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-2.77%
Inventory is declining while M7U.DE stands at 4.54%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.36%
Positive asset growth while M7U.DE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
9.63%
Similar to M7U.DE's 9.80%. Walter Schloss finds parallel capital usage or profit distribution strategies.
-1.92%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
42.06%
SG&A growth of 42.06% while M7U.DE is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.